Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 178369, 8 pages
http://dx.doi.org/10.1155/2015/178369
Research Article

AT-RvD1 Modulates CCL-2 and CXCL-8 Production and NF-κB, STAT-6, SOCS1, and SOCS3 Expression on Bronchial Epithelial Cells Stimulated with IL-4

1Institute of Health Sciences, Department of Clinical Medicine, Laboratory of Experimental Immunopharmacology, Federal University of Triangulo Mineiro, Street Vigário Carlos 162, 38025-350 Uberaba, MG, Brazil
2Institute of Biological and Natural Sciences, Department of Genetics, Federal University of Triangulo Mineiro, Uberaba, MG, Brazil
3Institute of Health Sciences, Department of Clinical Medicine, Federal University of Triangulo Mineiro, Uberaba, MG, Brazil
4Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA

Received 15 July 2014; Revised 22 September 2014; Accepted 23 September 2014

Academic Editor: Carlo Jose Oliveira

Copyright © 2015 Jhony Robison de Oliveira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Kelly-Welch, E. M. Hanson, M. R. Boothby, and A. D. Keegan, “Interleukin-4 and interleukin-13 signaling connections maps,” Science, vol. 300, no. 5625, pp. 1527–1528, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. H. Fanta, “Asthma,” The New England Journal of Medicine, vol. 360, no. 10, pp. 1002–1014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. W. W. Busse and R. F. Lemanske Jr., “Asthma,” The New England Journal of Medicine, vol. 344, no. 5, pp. 350–362, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Lloyd and E. M. Hessel, “Functions of T cells in asthma: more than just TH2 cells,” Nature Reviews Immunology, vol. 10, no. 12, pp. 838–848, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Hammad and B. N. Lambrecht, “Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma,” Nature Reviews Immunology, vol. 8, no. 3, pp. 193–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. Sha, A. Q. Truong-Tran, J. R. Plitt, L. A. Beck, and R. P. Schleimer, “Activation of airway epithelial cells by toll-like receptor agonists,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 3, pp. 358–364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Kato, S. Favoreto Jr., P. C. Avila, and R. P. Schleimer, “TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells,” The Journal of Immunology, vol. 179, no. 2, pp. 1080–1087, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. F. Kauffman, “Innate immune responses to environmental allergens,” Clinical Reviews in Allergy and Immunology, vol. 30, no. 2, pp. 129–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Bilyk and P. G. Holt, “Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor,” Journal of Experimental Medicine, vol. 177, no. 6, pp. 1773–1777, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Ebeling, T. Lam, J. R. Gordon, M. D. Hollenberg, and H. Vliagoftis, “Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway,” The Journal of Immunology, vol. 179, no. 5, pp. 2910–2917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kiss, M. Montes, S. Susarla et al., “A new mechanism regulating the initiation of allergic airway inflammation,” Journal of Allergy and Clinical Immunology, vol. 120, no. 2, pp. 334–342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. A. Stumbles, D. H. Strickland, C. L. Pimm et al., “Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus,” Journal of Immunology, vol. 167, no. 1, pp. 228–234, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Lilly, H. Nakamura, H. Kesselman et al., “Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids,” The Journal of Clinical Investigation, vol. 99, no. 7, pp. 1767–1773, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Reibman, Y. Hsu, L. C. Chen, B. Bleck, and T. Gordon, “Airway epithelial cells release MIP-3α/CCL20 in response to cytokines and ambient particulate matter,” American Journal of Respiratory Cell and Molecular Biology, vol. 28, no. 6, pp. 648–654, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. Webb, Y. Cai, K. I. Matthaei, and P. S. Foster, “Comparative roles of IL-4, IL-13, and IL-4Rα in dendritic cell maturation and CD4+ Th2 cell function,” The Journal of Immunology, vol. 178, no. 1, pp. 219–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Q. Wen, T. Kohyama, X. Liu et al., “Interleukin-4- and interleukin-13-enhanced transforming growth factor-β2 production in cultured human bronchial epithelial cells is attenuated by interferon-γ,” The American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 4, pp. 484–490, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. W. K. Ip, C. K. Wong, and C. W. K. Lam, “Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: Involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways,” Clinical and Experimental Immunology, vol. 145, no. 1, pp. 162–172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. N. Serhan, S. Hong, K. Gronert et al., “Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals,” The Journal of Experimental Medicine, vol. 196, no. 8, pp. 1025–1037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Eickmeier, H. Seki, O. Haworth et al., “Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury,” Mucosal Immunology, vol. 6, no. 2, pp. 256–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. P. Rogerio, O. Haworth, R. Croze et al., “Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses,” The Journal of Immunology, vol. 189, no. 4, pp. 1983–1991, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bonnans, D. Gras, C. Chavis et al., “Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells,” Biomedicine and Pharmacotherapy, vol. 61, no. 5, pp. 261–267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Cao, C. K. Wong, Y. Yin, and C. W. K. Lam, “Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-α: Implications for immunopathophysiology of airway inflammation,” Journal of Cellular Physiology, vol. 223, no. 3, pp. 788–797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Porter and A. Hall, “Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium,” FASEB Journal, vol. 23, no. 2, pp. 492–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. B. Thompson, R. A. Robbins, D. J. Romberger et al., “Immunological functions of the pulmonary epithelium,” European Respiratory Journal, vol. 8, no. 1, pp. 127–149, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. F.-Q. Wen, T. Kohyama, X. Liu et al., “Interleukin-4- and interleukin-13-enhanced transforming growth factor-β2 production in cultured human bronchial epithelial cells is attenuated by interferon-γ,” American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 4, pp. 484–490, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Wu, W. Tan, Q. Zhang, X. Zhang, and H. Song, “Effects of ozone exposure mediated by BEAS-2B cells on T cells activation: a possible link between environment and asthma,” Asian Pacific Journal of Allergy and Immunology, vol. 32, no. 1, pp. 25–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Nakamura, Y. Kamogawa, K. Bottomly, and R. A. Flavell, “Polarization of IL-4- and IFN-γ-producing CD4 + T cells following activation of naive CD4+ T cells,” The Journal of Immunology, vol. 158, no. 3, pp. 1085–1094, 1997. View at Google Scholar · View at Scopus
  29. D. Hebenstreit, P. Luft, A. Schmiedlechner et al., “IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site,” The Journal of Immunology, vol. 171, no. 11, pp. 5901–5907, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Gu, S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins, “Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1,” Nature, vol. 404, no. 6776, pp. 407–411, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. “Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2341–2351, 2000.
  32. S. Sur, T. B. Crotty, G. M. Kephart et al., “Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?” American Review of Respiratory Disease, vol. 148, no. 3, pp. 713–719, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. J. V. Fahy, K. W. Kim, J. Liu, and H. A. Boushey, “Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation,” Journal of Allergy and Clinical Immunology, vol. 95, pp. 843–852, 1995. View at Publisher · View at Google Scholar
  34. C. Lamblin, P. Gosset, I. Tillie-Leblond et al., “Bronchial neutrophilia in patients with noninfectious status asthmaticus,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 2, pp. 394–402, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. S. H. Twaddell, P. G. Gibson, K. Carty, K. L. Woolley, and R. L. Henry, “Assessment of airway inflammation in children with acute asthma using induced sputum,” European Respiratory Journal, vol. 9, no. 10, pp. 2104–2108, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. F. M. Konrad and J. Reutershan, “CXCR2 in acute lung injury,” Mediators of Inflammation, vol. 2012, Article ID 740987, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. F. Chung, “Inflammatory mediators in chronic obstructive pulmonary disease,” Current Drug Targets: Inflammation and Allergy, vol. 4, no. 6, pp. 619–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. C. Allen and A. Kurdowska, “Interleukin 8 and acute lung injury,” Archives of Pathology and Laboratory Medicine, vol. 138, no. 2, pp. 266–269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Todorović-Raković and J. Milovanović, “Interleukin-8 in breast cancer progression,” Journal of Interferon and Cytokine Research, vol. 33, no. 10, pp. 563–570, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Dhooghe, S. Noël, F. Huaux, and T. Leal, “Lung inflammation in cystic fibrosis: pathogenesis and novel therapies,” Clinical Biochemistry, vol. 47, no. 7-8, pp. 539–546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. J. Stuart and B. T. Baune, “Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies,” Neuroscience & Biobehavioral Reviews, vol. 42, pp. 93–115, 2014. View at Google Scholar
  42. E. H. Chung, Y. Jia, H. Ohnishi et al., “Leukotriene B4 receptor 1 is differentially expressed on peripheral T cells of steroid-sensitive and -resistant asthmatics,” Annals of Allergy, Asthma and Immunology, vol. 112, no. 3, pp. 211–216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. C. N. Serhan, “Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?” American Journal of Pathology, vol. 177, no. 4, pp. 1576–1591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. C. D. Russell and J. Schwarze, “The role of pro-resolution lipid mediators in infectious disease,” Immunology, vol. 141, no. 2, pp. 166–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Krishnamoorthy, A. Recchiuti, N. Chiang et al., “Resolvin D1 binds human phagocytes with evidence for proresolving receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1660–1665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. L. V. Norling, J. Dalli, R. J. Flower, C. N. Serhan, and M. Perretti, “Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1970–1978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Krishnamoorthy, A. Recchiuti, N. Chiang, G. Fredman, and C. N. Serhan, “Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving MicroRNAs,” American Journal of Pathology, vol. 180, no. 5, pp. 2018–2027, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Perretti, N. Chiang, M. La et al., “Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor,” Nature Medicine, vol. 8, no. 11, pp. 1296–1302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Wang, X. Gong, J.-Y. Wan et al., “Resolvin D1 protects mice from LPS-induced acute lung injury,” Pulmonary Pharmacology and Therapeutics, vol. 24, no. 4, pp. 434–441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Planagumà, S. Kazani, G. Marigowda et al., “Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma,” The American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 6, pp. 574–582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. P. J. Barnes and I. M. Adcock, “Glucocorticoid resistance in inflammatory diseases,” The Lancet, vol. 373, no. 9678, pp. 1905–1917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. Q. Guo, Y. Xu, and Z. Zhang, “Role of activator protein-1 in the transcription of interleukin-5 gene regulated by protein kinase C signal in asthmatic human T lymphocytes,” Journal of Huazhong University of Science and Technology, vol. 25, no. 2, pp. 147–150, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Nakamura and M. Hoshino, “TH2 cytokines and associated transcription factors as therapeutic targets in asthma,” Current Drug Targets: Inflammation and Allergy, vol. 4, no. 2, pp. 267–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. M. E. Poynter, R. Cloots, T. van Woerkom et al., “NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness,” Journal of Immunology, vol. 173, no. 11, pp. 7003–7009, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Iwata, S. Kawashima, M. Kobayashi et al., “Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity,” International Immunology, vol. 26, no. 2, pp. 103–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. Q. Fu, J. Wang, Z. Ma, and S. Ma, “Anti-asthmatic effects of matrine in a mouse model of allergic asthma,” Fitoterapia, vol. 94, pp. 183–189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. M. E. Rothenberg, A. D. Luster, and P. Leder, “Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 19, pp. 8960–8964, 1995. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Anrather, V. Csizmadia, C. Brostjan, M. P. Soares, F. H. Bach, and H. Winkler, “Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB,” The Journal of Clinical Investigation, vol. 99, no. 4, pp. 763–772, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Yang, L. Cohn, D.-H. Zhang, R. Homer, A. Ray, and P. Ray, “Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation,” The Journal of Experimental Medicine, vol. 188, no. 9, pp. 1739–1750, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. K. J. Serio, K. V. Reddy, and T. D. Bigby, “Lipopolysaccharide induces 5-lipoxygenase-activating protein gene expression in THP-1 cells via a NF-κB and C/EBP-mediated mechanism,” The American Journal of Physiology—Cell Physiology, vol. 288, no. 5, pp. 1125–1133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. E. M. Linossi, J. J. Babon, D. J. Hilton, and S. E. Nicholson, “Suppression of cytokine signaling: the SOCS perspective,” Cytokine and Growth Factor Reviews, vol. 24, no. 3, pp. 241–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Inagaki-Ohara, T. Kondo, M. Ito, and A. Yoshimura, “SOCS, inflammation, and cancer,” JAKSTAT, vol. 1, pp. 2–3, 2013. View at Google Scholar
  63. B. Carow and M. E. Rottenberg, “SOCS3: a major regulator of infection and inflammation,” Frontiers in Immunology, vol. 5, article 58, 2014. View at Publisher · View at Google Scholar
  64. D. C. Palmer and N. P. Restifo, “Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function,” Trends in Immunology, vol. 30, no. 12, pp. 592–602, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Li and S. Hua, “Mechanisms of pathogenesis in allergic asthma: role of interleukin-23,” Respirology, vol. 19, no. 5, pp. 663–669, 2014. View at Publisher · View at Google Scholar
  66. Y. Morishima, S. Ano, Y. Ishii et al., “Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma,” Clinical and Developmental Immunology, vol. 2013, Article ID 609395, 9 pages, 2013. View at Publisher · View at Google Scholar